Founded in 2004, Sundia MediTech Company, Ltd. is a leading pre-clinical contract research organization (CRO) providing a comprehensive and integrated portfolio of high-quality drug discovery and development services. Sundia's experienced R&D and international management team possess extensive experience across the fields of chemistry (custom synthesis, library design and synthesis), medicinal chemistry, biology (in vitro and in vivo), DMPK, pre-clinical studies, as well as pharmaceutical development (process research and development, API manufacturing, pre-formulation and formulation, analytical as well as QA/QC, CMC and IND filing) services. Sundia's primary research facilities, which include standard and kilo-labs, an animal facility, a pilot plant and other supporting facilities, are located in Shanghai (Zhangjiang Hi-Tech Park), Shijiazhuang and Taicang. For more information, please visit us at www.sundia.com or email us at info@sundia.com.